Castleark Management LLC Novo Cure LTD Transaction History

Castleark Management LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$124.11 - $190.17 $1.64 Million - $2.52 Million	-13,245 Closed	0 $0
Q4 2020 Feb 17, 2021	BUY	$112.16 - $174.14 $1.49 Million - $2.31 Million	13,245 New	13,245 $2.29 Million
Q2 2020 Aug 14, 2020	SELL	$57.2 - $74.41 $4.55 Million - $5.92 Million	-79,624 Closed	0 $0
Q1 2020 May 13, 2020	SELL	$57.05 - $95.75 $95,558 - $160,381	-1,675 Reduced 2.06%	79,624 $5.36 Million
Q4 2019 Feb 14, 2020	SELL	$68.3 - $93.8 $107,640 - $147,828	-1,576 Reduced 1.9%	81,299 $6.85 Million
Q3 2019 Nov 15, 2019	BUY	$61.86 - $97.8 $5.13 Million - $8.11 Million	82,875 New	82,875 $6.2 Million
Q2 2019 Aug 13, 2019	SELL	$42.22 - $63.23 $3.73 Million - $5.59 Million	-88,358 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$31.96 - $56.12 $5.09 Million - $8.93 Million	-159,155 Reduced 64.3%	88,358 $4.26 Million
Q4 2018 Feb 12, 2019	SELL	$28.72 - $52.63 $3.07 Million - $5.63 Million	-106,915 Reduced 30.17%	247,513 $8.29 Million
Q3 2018 Nov 15, 2018	SELL	$32.0 - $52.4 $336,800 - $551,510	-10,525 Reduced 2.88%	354,428 $18.6 Million
Q2 2018 Aug 15, 2018	SELL	$19.85 - $32.0 $239,331 - $385,824	-12,057 Reduced 3.2%	364,953 $11.4 Million
Q1 2018 May 15, 2018	SELL	$19.3 - $23.65 $899,823 - $1.1 Million	-46,623 Reduced 11.01%	377,010 $8.22 Million
Q4 2017 Feb 15, 2018	SELL	$16.3 - $21.9 $404,647 - $543,667	-24,825 Reduced 5.54%	423,633 $8.56 Million
Q3 2017 Nov 15, 2017	BUY	$18.05 - $21.75 $8.09 Million - $9.75 Million	448,458	448,458 $8.9 Million

263

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $3.23B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Castleark Management LLC, based on Form 13F filings with the SEC.

Stay updated on Castleark Management LLC with notifications on news.